China approves inhaled CanSino vaccine for clinical trials
China's drug authority has approved for clinical trials an inhaled COVID-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday.
Mar 23, 2021
0
4